HS
TYRA icon

HighVista Strategies’s Tyra Biosciences TYRA Stock Holding History

HighVista Strategies’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.9M Buy
184,774
+53,470
+41% +$1.77M 1.35% 20
2026
Q1 		$5.03M Buy
131,304
+96,218
+274% +$3.11M 1.39% 13
2025
Q4 		$922K Sell
35,086
-30,726
-47% -$564K 0.24% 116
2025
Q3 		$921K Buy
65,812
+40,850
+164% +$466K 0.23% 124
2025
Q2 		$239K Buy
24,962
+1,021
+4% +$9.7K 0.09% 143
2025
Q1 		$223K Hold
23,941
– – 0.09% 145
2024
Q4 		$333K Buy
23,941
+7,863
+49% +$143K 0.12% 136
2024
Q3 		$378K Hold
16,078
– – 0.13% 141
2024
Q2 		$257K Buy
+16,078
New +$277K 0.09% 136

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

HighVista Strategies's TYRA Position: Q2 2026 in Review

HighVista Strategies increased its Tyra Biosciences (TYRA) stake by 41% in Q2 2026, buying an estimated $1.77M and bringing the position to 184,774 shares worth $5.9M. The position accounts for 1.35% of the portfolio, ranked #20.

HighVista Strategies first reported a position in TYRA in Q2 2024 and has held it in 9 quarters since. 169 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • HighVista Strategies held 184,774 shares of Tyra Biosciences worth $5.9M as of Q2 2026.
  • HighVista Strategies bought 53,470 Tyra Biosciences shares in Q2 2026, an estimated $1.77M.
  • Tyra Biosciences made up 1.35% of HighVista Strategies's portfolio in Q2 2026, its #20 holding.
  • HighVista Strategies first reported a position in Tyra Biosciences in Q2 2024 and has held it in 9 quarters since.
  • 169 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on HighVista Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.